We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants
NSPRZ

Delisted

NSPRZ was delisted on the 14th of March, 2022.

Back to rankings

2 hedge funds and large institutions have $1K invested in InspireMD, Inc. Series B Warrants in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 4 → 2 (-2)

84% less capital invested

Capital invested by funds: $6.33K → $1K (-$5.33K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$325
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$95
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1K -$95 -11,900 -3%
AFM
2
Anson Funds Management
Texas
– -$325 -250,000 Closed

NSPRZ Hedge Fund Activity: Q4 2019 in Review

2 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2019, worth a combined $1K — down 84% from $6.33K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NSPRZ and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Anson Funds Management, exiting entirely with an estimated $325 sold.

  • 2 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2019, down from 4 in Q3 2019.
  • Funds reported $1K of InspireMD, Inc. Series B Warrants stock for Q4 2019, down 84% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q4 2019 and 2 closed out, a net change of -2 holders.
  • The largest InspireMD, Inc. Series B Warrants seller in Q4 2019 was Anson Funds Management, an estimated $325 sold.

Based on aggregated 13F filings for Q4 2019.